Literature DB >> 9561806

Arachidonic acid and human bone marrow stromal cells.

Y Denizot1, C Dulery, F Trimoreau, V Desplat, V Praloran.   

Abstract

Human bone marrow stromal cells regulate the growth of marrow hematopoietic progenitors by secreting cytokines. Arachidonic acid (AA) is the fatty acid precursor of prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) that modulate the growth of human bone marrow progenitors. We have investigated the incorporation of AA in human bone marrow stromal cell cultures, their production of PGE2 and LTB4 and the effect of AA on their growth. Gas chromatography analysis reveals the presence of AA in the human bone marrow plasma and in bone marrow stromal cell cultures. In stromal cells, [3H]-AA is incorporated into triglycerides and is later delivered into phospholipids. Prelabeling-chase experiments indicate a preferential incorporation of AA into phosphatidylethanolamine and no trafficking of labeled AA between phospholipid species. Bone marrow stromal cells release PGE2 and LTB4 in response to phorbol myristic acetate (PMA) (1 microM) and tumor necrosis factor alpha (TNF-alpha) (10 ng/ml). Exogenous AA (up to 1 microM) has no significant effect on cell growth. In conclusion, human bone marrow stromal cells capt exogenous AA and, thus, may participate to the control of marrow AA concentrations. They may also regulate human marrow hematopoiesis by secreting AA metabolites such as PGE2 and LTB4.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561806     DOI: 10.1016/s0167-4889(97)00157-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression.

Authors:  H Chkourko Gusky; J Diedrich; O A MacDougald; I Podgorski
Journal:  Obes Rev       Date:  2016-07-19       Impact factor: 9.213

2.  Arachidonic acid and freshly isolated human bone marrow mononuclear cells.

Authors:  Y Denizot; V Desplat; C Dulery; F Trimoreau; V Praloran
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

3.  Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer.

Authors:  Ashwin Sachdeva; Claire A Hart; Kyungmin Kim; Thomas Tawadros; Pedro Oliveira; Jonathan Shanks; Mick Brown; Noel Clarke
Journal:  Br J Cancer       Date:  2022-07-22       Impact factor: 9.075

4.  Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs.

Authors:  M D Brown; C A Hart; E Gazi; S Bagley; N W Clarke
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.